Closter Pharma Investment Ltd
Other service activities not elsewhere classified
Closter Pharma Investment Ltd contacts: address, phone, fax, email, website, shedule
Address: 35 Cherrywood Lane SM4 4HU Morden
Phone: +44-1443 3554046
Fax: +44-1245 7631347
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Closter Pharma Investment Ltd"? - send email to us!
Registration data Closter Pharma Investment Ltd
Register date: 2012-12-06
Register number: 08320352
Type of company: Private Limited Company
Get full report form global database UK for Closter Pharma Investment LtdOwner, director, manager of Closter Pharma Investment Ltd
Tomasz Sebastian Jezierski Director. Address: Cherrywood Lane, Morden, SM4 4HU, United Kingdom. DoB: April 1974, British
Tomasz Jezierski Director. Address: Cherrywood Lane, Morden, SM4 4HU, United Kingdom. DoB: April 1977, British
Jobs in Closter Pharma Investment Ltd vacancies. Career and practice on Closter Pharma Investment Ltd. Working and traineeship
Director. From GBP 5800
Plumber. From GBP 2100
Carpenter. From GBP 2600
Responds for Closter Pharma Investment Ltd on FaceBook
Read more comments for Closter Pharma Investment Ltd. Leave a respond Closter Pharma Investment Ltd in social networks. Closter Pharma Investment Ltd on Facebook and Google+, LinkedIn, MySpaceAddress Closter Pharma Investment Ltd on google map
Other similar UK companies as Closter Pharma Investment Ltd: Gainsborough Care Ltd | Gab Neni Limited | Eyeland Limited | Saxifrage Christian Ministries | Child Focused Care Limited
Registered at 35 Cherrywood Lane, Morden SM4 4HU Closter Pharma Investment Ltd is classified as a Private Limited Company registered under the 08320352 Companies House Reg No.. The firm was established 4 years ago. It 's been one year that Closter Pharma Investment Ltd is no longer identified under the name Closter. This firm declared SIC number is 96090 and their NACE code stands for Other service activities not elsewhere classified. 2014-12-31 is the last time when the accounts were reported. This firm has been an important part of this particular market for the last four years.
Given this specific firm's growth, it became necessary to acquire further company leaders: Tomasz Sebastian Jezierski and Tomasz Jezierski who have been supporting each other since 2012 to fulfil their statutory duties for the company.
